FDA Proposes Class II Status For External Pacemaker Pulse Generators, Analyzers
This article was originally published in The Gray Sheet
Executive Summary
External pacemaker pulse generators and pacing system analyzers would move from class III to class II with special controls in a Sept. 15 proposed order. For most of the products, the 510(k) route would be maintained, but triple-chamber PSAs would move from PMA to 510(k) review under the proposal. .
You may also be interested in...
FDA Panel Supports Class II Status For Oxygenation Circuit Devices, And Two Other Categories
The Circulatory System Devices Panel supported class II, with special controls, reclassification proposals from FDA for extracorporeal membrane oxygenators; external cardiac compressors; and external pacemaker pulse generators and triple chamber pacing system analyzers. But the panel had some additional requests for further action by the agency.
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.